Anixa Biosciences Ownership 2024 | Who Owns Anixa Biosciences Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

11.83%

Insider Ownership

5.06%

Retail Ownership

83.11%

Institutional Holders

35.00

Anixa Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	4.43%	0.00%	1,392,906	-	-	4,345,866	Mar 31, 2024
LAIRD NORTON TRUST COMPANY, LLC	1.92%	0.26%	604,235	235,400	63.82%	1,885,213	Mar 31, 2024
UBS GROUP AG	1.71%	0.00%	536,307	-44,271	-7.63%	1,673,278	Mar 31, 2024
MISSION WEALTH MANAGEMENT, LP	1.60%	0.04%	502,420	1,252	0.25%	1,567,551	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1.08%	0.00%	340,951	340,951	100.00%	1,063,767	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.02%	0.00%	320,148	7,676	2.46%	999,111	Mar 31, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	0.53%	0.03%	165,701	-	-	516,987	Mar 31, 2024
BLACKROCK INC.	0.49%	-	154,662	-2,135	-1.36%	482,546	Mar 31, 2024
JANE STREET GROUP, LLC	0.39%	0.00%	121,924	78,541	181.04%	380,403	Mar 31, 2024
BANK OF AMERICA CORP /DE/	0.37%	-	116,914	100,000	591.23%	364,772,000	Mar 31, 2024
STATE STREET CORP	0.34%	-	108,500	-	-	338,520	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.30%	0.00%	93,343	44,890	92.65%	291,230	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	0.28%	0.00%	87,050	-9,604	-9.94%	271,597	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.22%	0.00%	68,800	68,800	100.00%	215,000	Mar 31, 2024
NORTHERN TRUST CORP	0.20%	-	62,662	11,165	21.68%	195,505	Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.13%	0.00%	41,000	1,000	2.50%	128,000	Mar 31, 2024
CITADEL ADVISORS LLC	0.12%	-	38,254	21,559	129.13%	119,352	Mar 31, 2024
CI PRIVATE WEALTH, LLC	0.12%	0.00%	37,400	-	-	116,688	Mar 31, 2024
MORGAN STANLEY	0.12%	-	37,136	663	1.82%	115,864	Mar 31, 2024
GEMMER ASSET MANAGEMENT LLC	0.11%	0.01%	35,000	-	-	109,200	Mar 31, 2024

Anixa Biosciences's largest institutional shareholder is VANGUARD GROUP INC, holding 4.43% of the company's total share outstanding, currently valued at $4.35M. The top 10 institutional shareholders own together 13.53% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
LAIRD NORTON TRUST COMPANY, LLC	1.92%	0.26%	604,235	235,400	63.82%	1,885,213	Mar 31, 2024
MISSION WEALTH MANAGEMENT, LP	1.60%	0.04%	502,420	1,252	0.25%	1,567,551	Mar 31, 2024
TYLER-STONE WEALTH MANAGEMENT	0.07%	0.03%	21,008	-	-	65,545	Mar 31, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	0.53%	0.03%	165,701	-	-	516,987	Mar 31, 2024
GEMMER ASSET MANAGEMENT LLC	0.11%	0.01%	35,000	-	-	109,200	Mar 31, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.	0.04%	0.01%	13,900	-	-	43,368	Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP	0.06%	0.01%	18,554	18,554	100.00%	57,888	Mar 31, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	0.04%	0.00%	14,000	-	-	46,900	Mar 31, 2024
NATIONS FINANCIAL GROUP INC, /IA/ /ADV	0.05%	0.00%	15,000	-	-	46,800	Mar 31, 2024
STALEY CAPITAL ADVISERS INC	0.03%	0.00%	10,000	10,000	100.00%	31,200	Mar 31, 2024
PARK CIRCLE CO	0.00%	0.00%	500	-	-	1,560	Mar 31, 2024
DAKOTA WEALTH MANAGEMENT	0.05%	0.00%	15,000	-	-	46,800	Mar 31, 2024
SIMPLICITY WEALTH,LLC	0.04%	0.00%	13,969	13,969	100.00%	43,583	Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC	0.04%	0.00%	11,174	5,000	80.98%	34,863	Mar 31, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.	0.13%	0.00%	41,000	1,000	2.50%	128,000	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.30%	0.00%	93,343	44,890	92.65%	291,230	Mar 31, 2024
UBS GROUP AG	1.71%	0.00%	536,307	-44,271	-7.63%	1,673,278	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	5,535	2,832	104.77%	17,269	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.22%	0.00%	68,800	68,800	100.00%	215,000	Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	0.05%	0.00%	16,655	16,655	100.00%	51,964	Mar 31, 2024

The largest Anixa Biosciences shareholder by % of total assets is LAIRD NORTON TRUST COMPANY, LLC. The company owns 604.24K shares of Anixa Biosciences (ANIX), representing 0.26% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1.08%	0.00%	340,951	340,951	100.00%	1,063,767	Mar 31, 2024
LAIRD NORTON TRUST COMPANY, LLC	1.92%	0.26%	604,235	235,400	63.82%	1,885,213	Mar 31, 2024
BANK OF AMERICA CORP /DE/	0.37%	-	116,914	100,000	591.23%	364,772,000	Mar 31, 2024
JANE STREET GROUP, LLC	0.39%	0.00%	121,924	78,541	181.04%	380,403	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.22%	0.00%	68,800	68,800	100.00%	215,000	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.30%	0.00%	93,343	44,890	92.65%	291,230	Mar 31, 2024
CITADEL ADVISORS LLC	0.12%	-	38,254	21,559	129.13%	119,352	Mar 31, 2024
GOLDMAN SACHS GROUP INC	0.07%	-	20,501	20,501	100.00%	63,963	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.06%	-	20,200	20,200	100.00%	63,024	Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP	0.06%	0.01%	18,554	18,554	100.00%	57,888	Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	0.05%	0.00%	16,655	16,655	100.00%	51,964	Mar 31, 2024
SQUAREPOINT OPS LLC	0.05%	0.00%	15,897	15,897	100.00%	49,599	Mar 31, 2024
MARSHALL WACE, LLP	0.08%	0.00%	26,372	15,697	147.04%	82,280	Mar 31, 2024
SIMPLICITY WEALTH,LLC	0.04%	0.00%	13,969	13,969	100.00%	43,583	Mar 31, 2024
NORTHERN TRUST CORP	0.20%	-	62,662	11,165	21.68%	195,505	Mar 31, 2024
STALEY CAPITAL ADVISERS INC	0.03%	0.00%	10,000	10,000	100.00%	31,200	Mar 31, 2024
SIMPLEX TRADING, LLC	0.03%	-	9,051	8,758	2989.08%	28,000	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.02%	0.00%	320,148	7,676	2.46%	999,111	Mar 31, 2024
CITADEL ADVISORS LLC	0.05%	-	14,500	5,600	62.92%	45,240	Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC	0.04%	0.00%	11,174	5,000	80.98%	34,863	Mar 31, 2024

As of Mar 31 2024, Anixa Biosciences's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 340.95K stocks of ANIX, valued at $1.06M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	1.71%	0.00%	536,307	-44,271	-7.63%	1,673,278	Mar 31, 2024
RAYMOND JAMES & ASSOCIATES	0.06%	-	17,755	-37,894	-68.09%	55,396	Mar 31, 2024
CITADEL ADVISORS LLC	0.01%	-	4,100	-16,600	-80.19%	12,792	Mar 31, 2024
CONCORDE ASSET MANAGEMENT, LLC	-	-	-	-15,459	-100.00%	-	Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD	-	-	-	-14,372	-100.00%	-	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	0.28%	0.00%	87,050	-9,604	-9.94%	271,597	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-6,857	-100.00%	-	Mar 31, 2024
TRADITION WEALTH MANAGEMENT, LLC	-	-	-	-5,600	-100.00%	-	Mar 31, 2024
BLACKROCK INC.	0.49%	-	154,662	-2,135	-1.36%	482,546	Mar 31, 2024
LPL FINANCIAL LLC	0.08%	-	26,692	-1,450	-5.15%	83,279	Mar 31, 2024
GROUP ONE TRADING, L.P.	-	-	-	-1,285	-100.00%	-	Mar 31, 2024
ROYAL BANK OF CANADA	0.00%	-	1,000	-153	-13.27%	3,000	Mar 31, 2024
LARSON FINANCIAL GROUP LLC	0.00%	0.00%	500	-25	-4.76%	1,560,000	Mar 31, 2024
TYLER-STONE WEALTH MANAGEMENT	0.07%	0.03%	21,008	-	-	65,545	Mar 31, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC	0.53%	0.03%	165,701	-	-	516,987	Mar 31, 2024
GEMMER ASSET MANAGEMENT LLC	0.11%	0.01%	35,000	-	-	109,200	Mar 31, 2024
WESTSIDE INVESTMENT MANAGEMENT, INC.	0.04%	0.01%	13,900	-	-	43,368	Mar 31, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	0.04%	0.00%	14,000	-	-	46,900	Mar 31, 2024
NATIONS FINANCIAL GROUP INC, /IA/ /ADV	0.05%	0.00%	15,000	-	-	46,800	Mar 31, 2024
PARK CIRCLE CO	0.00%	0.00%	500	-	-	1,560	Mar 31, 2024

As of Mar 31 2024, Anixa Biosciences's biggest institutional seller is UBS GROUP AG. The company sold -44.27K shares of ANIX, valued at $1.67M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1.08%	0.00%	340,951	340,951	100.00%	1,063,767	Mar 31, 2024
GOLDMAN SACHS GROUP INC	0.07%	-	20,501	20,501	100.00%	63,963	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.06%	-	20,200	20,200	100.00%	63,024	Mar 31, 2024
OCCUDO QUANTITATIVE STRATEGIES LP	0.06%	0.01%	18,554	18,554	100.00%	57,888	Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	0.05%	0.00%	16,655	16,655	100.00%	51,964	Mar 31, 2024
SIMPLICITY WEALTH,LLC	0.04%	0.00%	13,969	13,969	100.00%	43,583	Mar 31, 2024
STALEY CAPITAL ADVISERS INC	0.03%	0.00%	10,000	10,000	100.00%	31,200	Mar 31, 2024
LAZARD ASSET MANAGEMENT LLC	0.00%	-	1,194	1,194	100.00%	3,000	Mar 31, 2024
FMR LLC	0.00%	-	250	250	100.00%	780	Mar 31, 2024

Anixa Biosciences's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 340.95K shares, valued at $1.06M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CONCORDE ASSET MANAGEMENT, LLC	-	-	-	-15,459	-100.00%	-	Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD	-	-	-	-14,372	-100.00%	-	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	-	-6,857	-100.00%	-	Mar 31, 2024
TRADITION WEALTH MANAGEMENT, LLC	-	-	-	-5,600	-100.00%	-	Mar 31, 2024
GROUP ONE TRADING, L.P.	-	-	-	-1,285	-100.00%	-	Mar 31, 2024

Anixa Biosciences's largest sold out institutional shareholder by shares sold is CONCORDE ASSET MANAGEMENT, LLC, sold -15.46K shares, valued at -, as of undefined.

Anixa Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.03%	12,599	-	-	Dec 31, 2023
BRIDGEWAY FUNDS INC	0.01%	21,000	-	-	Dec 29, 2023
VANGUARD INDEX FUNDS	0.00%	1,769,157	450,642	34.18%	Dec 31, 2023
AdvisorShares Trust	0.00%	8,093	-	-	Dec 29, 2023
FIDELITY CONCORD STREET TRUST	0.00%	289,688	13,980	5.07%	Feb 29, 2024
ETF Managers Trust	0.00%	7,644	-	-	Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	21,079	-	-	Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	14,225	-	-	Jan 31, 2024
WILSHIRE MUTUAL FUNDS INC	0.00%	3,590	-	-	Dec 31, 2023
Dimensional ETF Trust	0.00%	4,426	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	5,059	-	-	Dec 31, 2023
iSHARES TRUST	0.00%	65,668	-	-	Feb 29, 2024
NORTHERN FUNDS	0.00%	3,525	-	-	Dec 29, 2023
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	386	-	-	Dec 31, 2023

Anixa Biosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 12.60K shares, compromising 0.03% of its total assets.

Anixa Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	35	-36.36%
31 Dec, 23	55	10.00%
30 Sep, 23	50	11.11%
30 Jun, 23	45	-
31 Mar, 23	45	-10.00%
31 Dec, 22	50	25.00%
30 Sep, 22	40	-9.09%
30 Jun, 22	44	10.00%
31 Mar, 22	40	-4.76%
31 Dec, 21	42	16.67%
30 Sep, 21	36	16.13%
30 Jun, 21	31	14.81%
31 Mar, 21	27	35.00%
31 Dec, 20	20	-
30 Sep, 20	20	11.11%
30 Jun, 20	18	20.00%
31 Mar, 20	15	-
31 Dec, 19	15	-
30 Sep, 19	15	7.14%
30 Jun, 19	14	-
31 Mar, 19	14	7.69%
31 Dec, 18	13	-

As of 31 Mar 24, 35 institutions are holding Anixa Biosciences's shares, representing a decrease of -36.36% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	3,720,874	-14.22%
31 Dec, 23	4,337,492	11.45%
30 Sep, 23	3,891,710	8.42%
30 Jun, 23	3,589,599	2.30%
31 Mar, 23	3,508,872	-1.58%
31 Dec, 22	3,565,179	3.79%
30 Sep, 22	3,434,858	5.67%
30 Jun, 22	3,250,681	-1.63%
31 Mar, 22	3,304,604	-3.34%
31 Dec, 21	3,418,687	9.17%
30 Sep, 21	3,131,600	6.70%
30 Jun, 21	2,934,892	16.82%
31 Mar, 21	2,512,226	39.53%
31 Dec, 20	1,800,474	-1.45%
30 Sep, 20	1,826,961	14.37%
30 Jun, 20	1,597,366	15.47%
31 Mar, 20	1,383,319	3.86%
31 Dec, 19	1,331,888	1.45%
30 Sep, 19	1,312,871	7.03%
30 Jun, 19	1,226,634	-1.98%
31 Mar, 19	1,251,436	14.19%
31 Dec, 18	1,095,942	-

Anixa Biosciences (ANIX) has 3.72M shares outstanding as of 31 Mar 24, down -14.22% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	11.83%	6.04%
31 Dec, 23	14.00%	8.87%
30 Sep, 23	12.56%	9.33%
30 Jun, 23	11.61%	9.01%
31 Mar, 23	11.35%	8.54%
31 Dec, 22	11.53%	9.02%
30 Sep, 22	11.31%	9.92%
30 Jun, 22	10.68%	8.89%
31 Mar, 22	10.96%	8.51%
31 Dec, 21	11.35%	9.45%
30 Sep, 21	10.96%	11.80%
30 Jun, 21	9.64%	12.55%
31 Mar, 21	8.76%	17.12%
31 Dec, 20	7.15%	13.57%
30 Sep, 20	7.26%	15.27%
30 Jun, 20	6.90%	16.13%
31 Mar, 20	6.54%	15.80%
31 Dec, 19	6.43%	16.00%
30 Sep, 19	6.34%	17.03%
30 Jun, 19	6.10%	15.04%
31 Mar, 19	6.37%	19.49%
31 Dec, 18	5.72%	-

As of 31 Mar 24, Anixa Biosciences is held by 11.83% institutional shareholders, representing a 6.04% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	14	-30.00%
31 Dec, 23	20	53.85%
30 Sep, 23	13	-13.33%
30 Jun, 23	15	25.00%
31 Mar, 23	12	-36.84%
31 Dec, 22	19	35.71%
30 Sep, 22	14	-17.65%
30 Jun, 22	17	-5.56%
31 Mar, 22	18	-5.26%
31 Dec, 21	19	26.67%
30 Sep, 21	15	-6.25%
30 Jun, 21	16	-15.79%
31 Mar, 21	19	46.15%
31 Dec, 20	13	30.00%
30 Sep, 20	10	-9.09%
30 Jun, 20	11	83.33%
31 Mar, 20	6	-14.29%
31 Dec, 19	7	-12.50%
30 Sep, 19	8	14.29%
30 Jun, 19	7	-12.50%
31 Mar, 19	8	-38.46%
31 Dec, 18	13	-

14 institutional shareholders have increased their position in ANIX stock as of 31 Mar 24 compared to 20 in the previous quarter (a -30.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	6	-50.00%
31 Dec, 23	12	-14.29%
30 Sep, 23	14	100.00%
30 Jun, 23	7	-12.50%
31 Mar, 23	8	-38.46%
31 Dec, 22	13	85.71%
30 Sep, 22	7	-36.36%
30 Jun, 22	11	10.00%
31 Mar, 22	10	11.11%
31 Dec, 21	9	-10.00%
30 Sep, 21	10	100.00%
30 Jun, 21	5	-16.67%
31 Mar, 21	6	20.00%
31 Dec, 20	5	-
30 Sep, 20	5	25.00%
30 Jun, 20	4	-
31 Mar, 20	4	-20.00%
31 Dec, 19	5	150.00%
30 Sep, 19	2	-33.33%
30 Jun, 19	3	-25.00%
31 Mar, 19	4	-
31 Dec, 18	-	-

6 institutional shareholders have reduced their position in ANIX stock as of 31 Mar 24 compared to 12 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	35	-36.36%	3,720,874	-14.22%	11.83%	6.04%	14	-30.00%	6	-50.00%
31 Dec, 23	55	10.00%	4,337,492	11.45%	14.00%	8.87%	20	53.85%	12	-14.29%
30 Sep, 23	50	11.11%	3,891,710	8.42%	12.56%	9.33%	13	-13.33%	14	100.00%
30 Jun, 23	45	-	3,589,599	2.30%	11.61%	9.01%	15	25.00%	7	-12.50%
31 Mar, 23	45	-10.00%	3,508,872	-1.58%	11.35%	8.54%	12	-36.84%	8	-38.46%
31 Dec, 22	50	25.00%	3,565,179	3.79%	11.53%	9.02%	19	35.71%	13	85.71%
30 Sep, 22	40	-9.09%	3,434,858	5.67%	11.31%	9.92%	14	-17.65%	7	-36.36%
30 Jun, 22	44	10.00%	3,250,681	-1.63%	10.68%	8.89%	17	-5.56%	11	10.00%
31 Mar, 22	40	-4.76%	3,304,604	-3.34%	10.96%	8.51%	18	-5.26%	10	11.11%
31 Dec, 21	42	16.67%	3,418,687	9.17%	11.35%	9.45%	19	26.67%	9	-10.00%
30 Sep, 21	36	16.13%	3,131,600	6.70%	10.96%	11.80%	15	-6.25%	10	100.00%
30 Jun, 21	31	14.81%	2,934,892	16.82%	9.64%	12.55%	16	-15.79%	5	-16.67%
31 Mar, 21	27	35.00%	2,512,226	39.53%	8.76%	17.12%	19	46.15%	6	20.00%
31 Dec, 20	20	-	1,800,474	-1.45%	7.15%	13.57%	13	30.00%	5	-
30 Sep, 20	20	11.11%	1,826,961	14.37%	7.26%	15.27%	10	-9.09%	5	25.00%
30 Jun, 20	18	20.00%	1,597,366	15.47%	6.90%	16.13%	11	83.33%	4	-
31 Mar, 20	15	-	1,383,319	3.86%	6.54%	15.80%	6	-14.29%	4	-20.00%
31 Dec, 19	15	-	1,331,888	1.45%	6.43%	16.00%	7	-12.50%	5	150.00%
30 Sep, 19	15	7.14%	1,312,871	7.03%	6.34%	17.03%	8	14.29%	2	-33.33%
30 Jun, 19	14	-	1,226,634	-1.98%	6.10%	15.04%	7	-12.50%	3	-25.00%
31 Mar, 19	14	7.69%	1,251,436	14.19%	6.37%	19.49%	8	-38.46%	4	-
31 Dec, 18	13	-	1,095,942	-	5.72%	-	13	-	-	-

Anixa Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 10, 2024	Titterton Lewis H jr	director	-	P-Purchase	Buy	15,009	$3.28	$49.23K	838,037
Mar 15, 2024	Baskies Arnold M	director	-	P-Purchase	Buy	10,000	$3.63	$36.30K	110,000
Mar 15, 2024	KUMAR AMIT	officer	Chief Executive Officer	P-Purchase	Buy	30,000	$3.22	$96.60K	491,925
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	S-Sale	Sell	11,800	$3.57	$42.13K	461,925
Jul 21, 2023	Catelani Michael	officer	President, COO & CFO	P-Purchase	Buy	5,500	$3.64	$20.02K	26,655

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 10, 2024	Titterton Lewis H jr	director	-	P-Purchase	Buy	15,009	$3.28	$49.23K	838,037
Mar 15, 2024	Baskies Arnold M	director	-	P-Purchase	Buy	10,000	$3.63	$36.30K	110,000
Mar 15, 2024	KUMAR AMIT	officer	Chief Executive Officer	P-Purchase	Buy	30,000	$3.22	$96.60K	491,925
Jul 21, 2023	Catelani Michael	officer	President, COO & CFO	P-Purchase	Buy	5,500	$3.64	$20.02K	26,655

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Oct 11, 2023	Titterton Lewis H jr	director	-	M-Exempt	Sell	16,000	$2.58	$41.20K	-
Jul 31, 2023	Titterton Lewis H jr	director	-	F-InKind	Sell	87,042	$3.55	$309.00K	807,028
Jul 31, 2023	Titterton Lewis H jr	director	-	M-Exempt	Sell	120,000	$2.58	$309.00K	-
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	F-InKind	Sell	28,375	$3.63	$103.00K	473,725
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	S-Sale	Sell	11,800	$3.57	$42.13K	461,925
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	M-Exempt	Sell	40,000	$2.58	$103.00K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 02, 2024	Catelani Michael	officer	President, COO, & CFO	A-Award	Buy	1,189	$2.52	$3.00K	28,961
Apr 10, 2024	Titterton Lewis H jr	director	-	P-Purchase	Buy	15,009	$3.28	$49.23K	838,037
Mar 15, 2024	Baskies Arnold M	director	-	P-Purchase	Buy	10,000	$3.63	$36.30K	110,000
Mar 15, 2024	KUMAR AMIT	officer	Chief Executive Officer	P-Purchase	Buy	30,000	$3.22	$96.60K	491,925
Jan 16, 2024	Baskies Arnold M	director	-	A-Award	Buy	25,000	$4.39	$109.75K	25,000
Jan 16, 2024	Gottschalk Emily	director	-	A-Award	Buy	25,000	$4.39	$109.75K	25,000
Jan 16, 2024	Catelani Michael	officer	President, COO & CFO	A-Award	Buy	350,000	$4.39	$1.54M	350,000
Jan 16, 2024	KUMAR AMIT	director, officer	Chief Executive Officer	A-Award	Buy	700,000	$4.39	$3.07M	700,000
Jan 16, 2024	Titterton Lewis H jr	director	-	A-Award	Buy	25,000	$4.39	$109.75K	25,000
Nov 02, 2023	Catelani Michael	officer	President, COO & CFO	A-Award	Buy	1,117	$2.69	$3.00K	27,772
Oct 11, 2023	Titterton Lewis H jr	director	-	M-Exempt	Buy	16,000	$2.58	$41.20K	823,028
Oct 11, 2023	Titterton Lewis H jr	director	-	M-Exempt	Sell	16,000	$2.58	$41.20K	-
Jul 31, 2023	Titterton Lewis H jr	director	-	M-Exempt	Buy	120,000	$2.58	$309.00K	894,070
Jul 31, 2023	Titterton Lewis H jr	director	-	F-InKind	Sell	87,042	$3.55	$309.00K	807,028
Jul 31, 2023	Titterton Lewis H jr	director	-	M-Exempt	Sell	120,000	$2.58	$309.00K	-
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	M-Exempt	Buy	40,000	$2.58	$103.00K	502,100
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	F-InKind	Sell	28,375	$3.63	$103.00K	473,725
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	S-Sale	Sell	11,800	$3.57	$42.13K	461,925
Jul 31, 2023	KUMAR AMIT	director, officer	Chief Executive Officer	M-Exempt	Sell	40,000	$2.58	$103.00K	-
Jul 21, 2023	Catelani Michael	officer	President, COO & CFO	P-Purchase	Buy	5,500	$3.64	$20.02K	26,655

The last insider sell of Anixa Biosciences's stock was made by Titterton Lewis H jr on Oct 11 2023, selling 16,000 shares at $2.58 per share (valued at $41.20K). The last insider buy of ANIX was made by Titterton Lewis H jr on Apr 10 2024, buying 15,009 shares at $3.28 per share (worth $49.23K).

Anixa Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	2	-	-
Q1 2024	7	-	-
Q4 2023	2	1	200.00%
Q3 2023	3	5	60.00%
Q2 2023	1	-	-
Q1 2023	10	-	-
Q4 2022	1	-	-
Q3 2022	2	4	50.00%
Q2 2022	8	1	800.00%
Q1 2022	15	-	-
Q4 2021	3	-	-
Q3 2021	9	-	-
Q2 2021	11	1	1100.00%
Q1 2021	5	1	500.00%
Q4 2020	3	-	-
Q3 2020	7	-	-
Q2 2020	4	-	-
Q1 2020	8	-	-
Q4 2019	8	1	800.00%
Q3 2019	19	5	380.00%

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Anixa Biosciences's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	1	-	-
Q1 2024	2	-	-
Q4 2023	-	-	-
Q3 2023	1	1	100.00%
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	3	-	-
Q1 2022	5	-	-
Q4 2021	2	-	-
Q3 2021	9	-	-
Q2 2021	3	-	-
Q1 2021	5	-	-
Q4 2020	-	-	-
Q3 2020	2	-	-
Q2 2020	3	-	-
Q1 2020	8	-	-
Q4 2019	-	-	-
Q3 2019	2	-	-

As of Q2 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Anixa Biosciences's stocks.

Anixa Biosciences Peer Ownership

Ticker	Company
ANTX	AN2 Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
MLYS	Mineralys Therapeutics, Inc.
RZLT	Rezolute, Inc.
PMVP	PMV Pharmaceuticals, Inc.
TFFP	TFF Pharmaceuticals, Inc.
PYPD	PolyPid Ltd.
INAB	IN8bio, Inc.
AVTE	Aerovate Therapeutics, Inc.
ACRV	Acrivon Therapeutics, Inc. Common Stock
CUE	Cue Biopharma, Inc.
ACLX	Arcellx, Inc.
ADAG	Adagene Inc.
MOLN	Molecular Partners AG
ANVS	Annovis Bio, Inc.
INMB	INmune Bio, Inc.
IMNM	Immunome, Inc.

ANIX Ownership FAQ

Who Owns Anixa Biosciences?

Anixa Biosciences is owned by institutional shareholders (11.83%), insiders (5.06%), and public (83.11%). The largest institutional shareholder of Anixa Biosciences is VANGUARD GROUP INC (4.43% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).

Who are the major institutional shareholders of Anixa Biosciences?

Anixa Biosciences's major institutional shareholders are VANGUARD GROUP INC, LAIRD NORTON TRUST COMPANY, LLC, UBS GROUP AG, MISSION WEALTH MANAGEMENT, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. The top five shareholders own together 10.74% of the company's share outstanding.

How many Anixa Biosciences shareholders are there?

As of Mar 2024, there are 35 institutional shareholders of Anixa Biosciences.

What percentage of Anixa Biosciences is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 1.39M shares of Anixa Biosciences, representing 4.43% of the company's total shares outstanding, valued at $4.35M (as of Mar 2024).

What percentage of Anixa Biosciences is owned by LAIRD NORTON TRUST COMPANY, LLC?

As of Mar 2024, LAIRD NORTON TRUST COMPANY, LLC holds 604.24K shares of Anixa Biosciences (ANIX), compromising 1.92% of the company, valued at $1.89M.

What percentage of Anixa Biosciences is owned by UBS GROUP AG?

UBS GROUP AG is the third largest holder of Anixa Biosciences. The company owns 536.31K of the company's shares outstanding (worth $1.67M).